ATE271384T1 - Arylnitron therapeutische mittel zur behandlung von entzündlichen darmerkrankungen - Google Patents
Arylnitron therapeutische mittel zur behandlung von entzündlichen darmerkrankungenInfo
- Publication number
- ATE271384T1 ATE271384T1 AT99922983T AT99922983T ATE271384T1 AT E271384 T1 ATE271384 T1 AT E271384T1 AT 99922983 T AT99922983 T AT 99922983T AT 99922983 T AT99922983 T AT 99922983T AT E271384 T1 ATE271384 T1 AT E271384T1
- Authority
- AT
- Austria
- Prior art keywords
- treatment
- inflammatory bowel
- bowel disease
- arylnitron
- therapeutic agents
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Pain & Pain Management (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Rheumatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US8596198P | 1998-05-19 | 1998-05-19 | |
PCT/US1999/010442 WO1999059576A1 (en) | 1998-05-19 | 1999-05-18 | Aryl nitrone therapeutics for the treatment of inflammatory bowel disease |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE271384T1 true ATE271384T1 (de) | 2004-08-15 |
Family
ID=22195102
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT99922983T ATE271384T1 (de) | 1998-05-19 | 1999-05-18 | Arylnitron therapeutische mittel zur behandlung von entzündlichen darmerkrankungen |
Country Status (11)
Country | Link |
---|---|
EP (1) | EP1077694B1 (de) |
AT (1) | ATE271384T1 (de) |
AU (1) | AU3985599A (de) |
CA (1) | CA2332462A1 (de) |
DE (1) | DE69918826T2 (de) |
DK (1) | DK1077694T3 (de) |
ES (1) | ES2224660T3 (de) |
NZ (1) | NZ508176A (de) |
PT (1) | PT1077694E (de) |
SI (1) | SI1077694T1 (de) |
WO (1) | WO1999059576A1 (de) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
UA66401C2 (en) | 1998-12-02 | 2004-05-17 | Sentor Pharmaceuticals Inc | 3,4,5-trisubstituted aryl nitrone compounds and pharmaceutical composition containing the same |
US6730700B2 (en) | 1998-12-02 | 2004-05-04 | Renovis, Inc. | 3,4,5,-trisubstituted aryl nitrone compounds and pharmaceutical compositions containing the same |
US20050182060A1 (en) * | 2004-02-13 | 2005-08-18 | Kelly Michael G. | 2-Substituted and 4-substituted aryl nitrone compounds |
ES2395803B1 (es) * | 2011-08-01 | 2013-12-19 | Consejo Superior De Investigaciones Científicas (Csic) - 80% | Quinolilnitronas |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5036097A (en) * | 1989-10-17 | 1991-07-30 | Oklahoma Medical Research Foundation | Phenylbutyl nitrone compositions and methods for prevention of gastric ulceration |
WO1992022290A1 (en) * | 1991-06-18 | 1992-12-23 | Oklahoma Medical Research Foundation | Use of spin trapping for the treatment of diseases associated with oxidation of lipids and proteins |
US5292746A (en) * | 1991-09-12 | 1994-03-08 | Merrell Dow Pharmaceuticals Inc. | Cyclic nitrones, pharmaceutical compositions thereof and their use in treating shock |
US5455272A (en) * | 1993-10-22 | 1995-10-03 | Oklahoma Medical Research Foundation | Spin trap nitronyl hindered phenols |
AU721531B2 (en) * | 1996-04-23 | 2000-07-06 | Renovis, Inc. | Compositions comprising a nitrone compound for use in treating ocular inflammation |
MA26553A1 (fr) * | 1997-10-17 | 2004-12-20 | Centaur Pharmaceuticals Inc | Alpha-aryl-n-alkylnitrones et compositions pharmaceutiques contenant ceux-la |
-
1999
- 1999-05-18 DK DK99922983T patent/DK1077694T3/da active
- 1999-05-18 PT PT99922983T patent/PT1077694E/pt unknown
- 1999-05-18 EP EP99922983A patent/EP1077694B1/de not_active Expired - Lifetime
- 1999-05-18 DE DE69918826T patent/DE69918826T2/de not_active Expired - Fee Related
- 1999-05-18 CA CA002332462A patent/CA2332462A1/en not_active Abandoned
- 1999-05-18 SI SI9930635T patent/SI1077694T1/xx unknown
- 1999-05-18 WO PCT/US1999/010442 patent/WO1999059576A1/en active IP Right Grant
- 1999-05-18 AU AU39855/99A patent/AU3985599A/en not_active Abandoned
- 1999-05-18 AT AT99922983T patent/ATE271384T1/de not_active IP Right Cessation
- 1999-05-18 NZ NZ508176A patent/NZ508176A/en unknown
- 1999-05-18 ES ES99922983T patent/ES2224660T3/es not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
AU3985599A (en) | 1999-12-06 |
CA2332462A1 (en) | 1999-11-25 |
NZ508176A (en) | 2004-01-30 |
EP1077694A1 (de) | 2001-02-28 |
DK1077694T3 (da) | 2004-11-22 |
DE69918826D1 (de) | 2004-08-26 |
EP1077694B1 (de) | 2004-07-21 |
WO1999059576A1 (en) | 1999-11-25 |
DE69918826T2 (de) | 2004-12-02 |
PT1077694E (pt) | 2004-12-31 |
ES2224660T3 (es) | 2005-03-01 |
SI1077694T1 (en) | 2004-10-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE308997T1 (de) | Mittel zur behandlung von erkrankungen der speiseröhre | |
DE60329316D1 (de) | Phenylcarboxamide als beta-sekretase-hemmer zur behandlung von alzheimer | |
EA200900802A1 (ru) | Способы и композиции для лечения амилоидных заболеваний | |
EA200600078A1 (ru) | Способы и композиции для лечения амилоидных заболеваний | |
DE69807115D1 (de) | Angiostatische verbindungen und zusammensetzungen zur behandlung des glc1a glaukoms | |
TNSN99171A1 (fr) | 4-carboxyamino-2-substitue-1,2,3,4-tetrahydroquinoleines, procede pour leur preparation et compositions pharmaceutiques les contenant | |
BR9502707A (pt) | Composto composição farmacêutica e método para o tratamento de uma afecção | |
DK0468012T3 (da) | 17beta-substituerede 4-aza-5alfa-androstan-3-on-derivater og fremgangsmåde til fremstilling deraf | |
ATE411026T1 (de) | Mittel zur behandlung der alzheimer-krankheit | |
DE60123238D1 (de) | Zusammensetzungen zur behandlung von autoimmunkrankheiten | |
ATE238792T1 (de) | Verwendung von makroliden zur behandlung von glaukom | |
ATE263777T1 (de) | Zusammensetzungen zur behandlung von entzündungsreaktionen | |
DE69519577D1 (de) | Prednisolonmetasulfobenzoatzusammensetzung zur behandlung von entzündungserkrankung des darmes | |
ATE260282T1 (de) | Aromatische ester von camptothecinen und verfahren zur behandlung von krebserkrankungen | |
PT971922E (pt) | Compostos de tetra-hidropirido | |
DE69918972D1 (de) | Verwendung von nmda-antagonisten und/oder natriumkanalantagonisten zur behandlung von entzündlichen erkrankungen | |
DE602004028574D1 (de) | Zusammensetzungen und verfahren zur behandlung des reizdarmsyndroms und von nichtulzeröser dyspepsie | |
ATE312104T1 (de) | Verbindungen zur behandlung von beeinträchtigten fundischen entspannung | |
DE60018704D1 (de) | Bretyliumhaltige zusammensetzungen und kits und deren verwendung zur vorbeugung und behandlung cardiovaskulärer erkrankungen | |
ATE225171T1 (de) | Aminosäurederivate zur behandlung von schlaganfall | |
DE602004021363D1 (de) | Imidazotriazin verbindungen zur behandlung von krebserkrankungen | |
DE69913380D1 (de) | Zusammensetzung zur behandlung von periodontalen erkrankungen | |
DE60131968D1 (de) | PYRANOÄ2,3-cÜIMIDAZOÄ1,2-aÜPYRIDIN-DERIVATE ZUR BEHANDLUNG VON GASTROINTESTINALEN ERKRANKUNGEN | |
ATE271384T1 (de) | Arylnitron therapeutische mittel zur behandlung von entzündlichen darmerkrankungen | |
DE60010934D1 (de) | Medikamente geeignet zur Behandlung von proliferativen Erkrankungen |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification |
Ref document number: 1077694 Country of ref document: EP |
|
REN | Ceased due to non-payment of the annual fee |